Funding for this research was provided by:
National Cancer Institute (R01 CA151326, R01 CA207290)
Received: 8 May 2019
Accepted: 9 August 2019
First Online: 4 September 2019
Ethics approval and consent to participate
: Institutional IRB approval was obtained (FHCRC IRO#7206).
: Not applicable.
: The authors disclose research grants and/or non-financial research support from GE Healthcare (SCP, HR, DSH), Philips Healthcare (SCP, HR, DSH), Toshiba America Medical Systems (DSH), and Siemens Medical Solutions USA (DSH) outside the submitted work. The other authors declare that they have no competing interests.